Patents Assigned to Carderm Capital L.P.
  • Diltiazem formulation
    Patent number: 5470584
    Abstract: The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles.
    Type: Grant
    Filed: February 27, 1995
    Date of Patent: November 28, 1995
    Assignee: Carderm Capital L.P.
    Inventors: Dennis L. Hendrickson, Dan C. Dimmitt, Mark S. Williams, Paul F. Skultety, Michael J. Baltezor
  • Diltiazem formulation
    Patent number: 5439689
    Abstract: The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: August 8, 1995
    Assignee: Carderm Capital L.P.
    Inventors: Dennis L. Hendrickson, Dan C. Dimmitt, Mark S. Williams, Paul F. Skultety, Michael J. Baltezor
  • Diltiazem formulation
    Patent number: 5286497
    Abstract: The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles.
    Type: Grant
    Filed: May 6, 1993
    Date of Patent: February 15, 1994
    Assignee: Carderm Capital L.P.
    Inventors: Dennis L. Hendrickson, Dan C. Dimmitt, Mark S. Williams, Paul F. Skultety, Michael J. Baltezor